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ABSTRACT
Classed as an epidemic by the World Health Organisation, obesity is the
result of an imbalance between energy input (food intake) and energy
expenditure. Evidence is starting to emerge to support the view that an
increase in the consumption of herbs. is an effective strategy for obesity
control and weight management. The use of plants has potential to keep the
increasing prevalence of metabolic syndrome in check like obesity. There are
few drugs in the market to ameliorate or prevent obesity but there are the
costs, efficacy and side effects to consider. For centuries people across the
countries have been using natural products and plant based dietary
supplements for weight control. The current review will consists of one
South Asian herb, Garcinia cambogia and one Chinese herb, Magnolia
officinalis. Both herbs are very effective and acting through two different
pathways. It is clearly evident from published information that the
hydroxycitric acid from Garcinia cambogia is most acceptable considering
its safety and efficacy properties.
INTRODUCTION
Obesity and the metabolic syndrome continue to plague the world at an
alarming rate. In recent years it has been reported that obesity and its
metabolic complications will cause both substantial socio-economic and
physical burden on society (1,2). Furthermore, if untreated diabetes,
hypertension, dyslipidemia and others more severe conditions will increase
(3). Because weight perturbations are so prevalent and harmful, many
different pro-pharmacological approaches have been developed to treat the
overweight state and obesity. The use of pharmacological drugs has become a
popular means to overcome excess weight (4). While these drugs generally
are effective, severe adverse toxicities may limit their overall usefulness
(5,6). A nutritional based intervention is being hailed as an inexpensive
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alternative to the aid weight loss, and weight management (7). Accordingly,
recent preliminary reports suggesting that herbs with a long ?i~tory.of use
and other natural substances less likely to produce severe toxICIty mIght be
effective in reducing appetite and promoting significant weight loss are
encouraging (Table I). ..
New weight loss strategies have focussed on dIfferent mechamsms of
products. This review will exa~ine th.e ro~e of ~wo I.ead natura~ pro~uct
interventions that can be used 10 conjunctIon wIth dIetary mampulatlOn,
which in turn may aid an individual's ability to achieve weight loss, while
maintaining key vitamins and mineral composition. In response to new
understanding of obesity and weight management science, the current review
will consists of one South Asian herb, Malabar tamarind tropical fruit
(Garcinia cambogia) and one Chinese herb, magnolia (Magnolia officinalis).
Both herbs are very promising and acting through two different pathways.
Table 1. Common dietary supplements used for weight loss I
'Adapted and modified from Saper et al. (37)
Increased energy Increased fat oxidation or Anxiolytic effect
expenditure reduced fat synthesis Magnolia
Ephedra Hydroxycitric acid Phellodendron
Bitter orange Green tea Miscellaneous or
Guarana Licorice unspecified
Caffeine Conjugated linoleic acid Laminaria
Country mallow Vitamin Bs Spirulina
Yerba mate Block dietary fat absorption Guggul
Modulate carbohydrate Chitosan Apple cider vinegar
metabolism Increased water absorption
Chromium Dandelion
Ginseng Cascara
Increased satiety Enhanced mood




The Indian fruit Garcinia cambogia (family Guttiferae), also known as
Malabar tamarind, which has been used safely for centuries in south-eastern
Asia as a food preservative, flavouring agent and carminative and also to
render meals more filling. The active ingredient (l0-30%) of the fruit rind is
(-)-hydroxycitric acid (RCA), a component that reportedly promotes weight
loss in part throu"h number of mechanisms. Two of the major mechanisms, , b
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are m~~bol~c .a~d appetite suppressant effect (8, Fig. I). feA is a
competItive tnhJb'tor of adenosine 5'-triphosphate-citrate lyase, leading to
decreased acetyl coenzyme A production and decreased fatty acid synthesis
(9,10). ~he putative weigh~ reduction effect of HCA is due to suppression of
~atty aCI.d and fat synthesIs. In addition, HCA is thought to suppress feed
mtak~ via loss of appetite by stimulation of liver gluconeogenesis (II). As
mentIOned, RCA has been shown to uppress food intake (I 2, J3) and to
decrease body weight gain (12,14), but the mechanisrn of the feedin o
suppressive effect of HCA is still unidentified. The findings Ulat RCA
dc:creased. the energy conversion ratio (12,13) and weight gain compared
With a pan-fed con~ol group supports the idea that HCA increases energy
ex~endltul'e. In th,s context, Leonhardt et al. (I I) has demon trated Ul




Figure 1..Proposed. biochemical action of HCA. Adapted from Soni et al.
(8). Copynght Perrrussion from Elsevier.
Se:era~ . in vivo studies have shown that HCA increases the
releas~avatlablh,ty of serotonin, neurotransmitter implicated in the regulation
of eatmg behavlOur ~d appetite control (I 5, 16). It is also reported that
~~~racts. ~f :r,cambogta decrease serum leptin, a hormone produced by fat
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metabolism levels in mice (17) and in humans (18), and also reduce the
expression of abdominal fat leptin in rats at doses that wouJd b~ appropriate
for human dietary consumption of HCA (19). A recent randomIzed, double-
blind clinical trial of G. cambogia revealed, in comparison with a placebo
group, 'ignificanl changes in the body composition improvement index and
decreases in the body fat of 0 erweight subjects who had received the dietary
supplement over a 12 week period (20).
Although HCA-SX (a ca1cium-potassium-HCA extract) seems to be
conditionally effective in weight management in both experimental animals
and humans, but its mechanism of action remains unclear.· Several in vitro
studies (19, 21) have shown that HCA-SX supplementation up-regulated the
genes encoding serotonin receptors and neuropeptide signalling, which
demonstrate its ability to suppress appetite (Table 2).
HCA-SX has also been shown to modulate a significant number of
genes including prostaglanclin D syntbase (pGDS), aldolase B, lipocalin 2,
fructose-I,6-biphosphatase I and low-density lipoprotein receptor related
protein 2, which playa prominent role in lipid metabolism, carbohydrate
metabolism, glycoJysis, and cell communication (J 9, Table 3). In a recent in
vitro microarray analysis, Roy et a1. (19) has demonstrated down-regulation
of 348 and up-regulation of 366 fat- and obesity-related genes. This study has
directed guidance in generating a new hypothesis, Le., transactivation of
hypoxia inducible factor (HIP) in the management of obesity.
Table 2. Genes upregulated following HCA-SX supplementation I
Genes/reeu1atory proteins Function
PDZ domain containing I Serotonin receptor signalling
5-Hydroxytryptamine (serotonin) receptor 2A Serotonin receptor
5-Hydroxytryptamine (serotonin) receptor 2B Serotonin receptor
5-Hydroxytryptamine (serotonin) receptor 3a Serotonin receptor
5-Hydroxytryptamine (serotonin) receptor 4 Serotonin receptor
5-Hydroxytryptamine (serotonin) receptor 7 Serotonin receptor
Prepoenkephalin, related sequence Neuropeptide signalling




Low-density lipoprotein receotor-related protein 2 Lipid metabolism
IAdapted from Downs et a1. (21). Copyright Permission from Elsevier
This review will examine two proprietary products of HCA from
G.cambogia, Super CitriMax®, a novel calcium/potassium-HCA extract
--------
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(HCA-SX) and Slim339®, tixed combination of G.cambogia with calcium
pantothenat~. The Su~er CitriMax® has been studied extensively in animal
m?del an~ m rand01UJs~d human clinical trials (8,18,19,21,22) and compare
w.lt.h relatl~eIy less studIed product, Slim339® (23). Super CitriMax® (Fi .
~) IS ~onslderably more soluble and bioavailable than calcium-based HC~
1I1gredlents (21).
Table 3. Genes downregulated following HCA-SX supplementation I
Geneslrel!ulatory proteins
Function
Beta Ii spectrin-short isoform mRNA, partial cds structural
C151_RAT platelet endothelial tetraspan antigen 3 cell contactSPARC-Iike I
structuralInhibitor of DNA binding 3
cell cycleFicolin 2 precursor
sugar binding
Synaptic vesicle glycoprotein 2b
calcium binding
Nonerythrocyte beta-spectrin mRNA, partial cds structural
IAdapted and modified from Roy et aI. (19)
_ . In on~ ri.gorous safety assessment it was reported that there is
suffiCient qualItatIve and. quantitative scientific evidence, including animal
and hun~an data suggestlJlg the intake of HCA-SX at levels up to 4667
~ng/day IS safe f?r hu~an .c?nsumption (8). HCA-SX has been shown to
~ncrease serotol~J~ avaIlabilIty, reduce appetite, increase fat oxidation
Impr?Ve blood lipId levels, reduce body weight, and modulate a number of
obeSIty regul~tory ge.nes (fable 23) without affecting the mitochondrial and
nuclear proteins ~equJred for ".orma! biochemical and physiological functions
(21), The combmed results from two randomised double-bl' d I b
t lied I' . , In • pace 0-
con r~ . c Imcal studies indicated that HCA-SX and to a greater dearee the
combmatlon of I-ICA-SX plus niacin-bound chromium and G;f1l11~ma
sylvestre extract reduce body weioht and BMI suppress a t't .
bl dr' . 0 , ppe I e, Improve
~ 00 . Ipl.d profiles, Increase serum Ieptin and serotonin levels and increase
aat oXldauon more Ihan placebo (18,22).
A dO~ble-bli~d, randomized parallel-group, placebo-controlled study
~~. b;;;fJcamed OU.I In order (0 evaluate the effect of orally self-administered
.nn .' a propnetary fixed combination of Garcinia cambogia extract
~Vlth c~lclUm p~ntoth~na(e (standardiZed for the content of hydroxycitric acid
d
and
pdntothemc aCid) and extracts of Matricaria cl1l111lomilla Ro"(/
amascena La (( .1 l ,#; " " , ' .,. . . , v nc u.a oJJlctna IS and Cananga odol'ata, 011 body weight in
ovelwelght and obese volunt er (21) nll";nn " ~{\ ,J __ .•
H
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DISCUSSION
The World Health Organization has recognized the epidemic of obesity as
one of the top ten global health problems (2). Obesity is the result of an
imbalance between energy input (food intake) and energy expenditure.
Obesity appears in most individuals as a multi-genic, multi-factorial disease.
Genetic determinants are account for at least 50 per cent of the obese
phenotype, whereas the rest is due to the environment (33). Obesity is
associated to several chronic and debilitating conditions including coronary
artery disease, metabolic syndrome, hypertension stroke hyperlipidemia,
diabetes, osteoarthritis, sleep apnoea, gout,. gaBbladder disease, several
cancers and joint problems (34).
There are few drugs in the market to ameliorate or prevent obesity but there
are the costs, efficacy and side effects to consider. For centuries people have
used plants for healing and the use of plants has potential to keep the
increasing prevalence of metabolic syndrome in check. Many people across
herb, Magnolia (M. officinalis) has been used specifically to control elevated
stress-related cortisol level, sweet cravings, disrupted weight management,
and poor quality of sleep (24), This particular herb has long history of
traditional use in Chinese medicine.
Clinical studies have shown that the oriental herbal medicine
sawoku-to (from Magnolia spp.) relieves anxiety-relat(',d disorders such as
anxiety neurosis (28). Several mechanistic studies suggest that the anxiolytic
effect of Magnolia compounds act as GABA-A receptor agonists (29), or
more precisely via an indirect cholinergic activity such as inhibition of
histaminergic neurons linked to cholinergic neurones (30,31). The Magnolia
fraction also demonstrated very significant binding to the adenosine AI,
glutamate N-methyl-D-a~:partate (NMDA) and serotonin transporter
receptors. Several clinical data confirm the efficacy and safety of the
Magnolia as a dietary supplement for supporting weight loss during stress
period. In one ongoing placebo controlled, double-blinded clinical study the
Magnolia supplement group show very encouraging result than a matching
placebo control at the dosage of I capsule (250 mg) three times daily for 6
weekly in 26 healthy overweight, pre-menopausal female adults (24), The
Magnolia supplemented group showed a statistically great reduction in
anxiety and non-significant trend for lowered average cortisol. An earlier
placebo controlled, double-blinded pilot study (32) demonstrated that the
supplement was well tolerated with no side-effects at the recommended
human dosage. Appetite for snaking was also significantly reduced in the








Magnolia ojjicinalis , " ' ) A
Obesity and work-related stress level is relatIvely hIgh 10 Amencan (24..
ear of 2000 Labour Day Gallup Poll suggests t?at 80 pe~cent. of A~e~~n
~orkers feel stress on their jobs (25). They descnb,~d the s.ltuatlon as thl~ IS
an overweight nation that is gripped by stress . PrevIous research .as
demonstrated a strong linkage between stress, lack of sleep and ObesIty
(26,27). A new approach to weight 10 s has been developed by ma~aging
stress leveL Reduction of the effects of stress on the body, a feelmg of
reduced anxiety and stress, and redu~ed crav,ings for comfort foods can ~e
possible by normalization of circulatmg cortisol levels. In r:s.ponse t~ thJS
d d ' of obes'lty and weight manacrement a traditIOnal ChlOesenew un erstan mg b
Figure 2. Structure of HCA-SX
I
. . '
[Adapted from Downs et al. (21). Copyright PernnsslOn from ElseVIer.
. . b d ei<rht for the <Troup receiving Slim339 was
averaoe reductIon JI1 0 Y w O, f >3 kcr
o cd' I 063°1 for the placebo group. WeIght losses 0 -- 0467% compm' WIt 1 , 70 1 . tt
~cre recorded for 23 subjects in the treatment group ~nd on y ~ne l~ Ie
lacebo rou. No pharmacokinetics and toxicity studIes hav~ ,~en, one.
p g d' P, 'II b eded to assess whether long term adl11Jntstratlon of
Further stu les WI e ne . ' uld improve the
this medication is warranted and to what degl ee I~ ~o . '
'. .,' obese subiect From prehmmary study, It IS
metabohc parameters 10 • J • _' .
concluded that Slim339® represents a potential therapy for obeSIty,
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the countries are using natural products and plant based dietary supplements
for weight loss (35). . d' lJ
During last decade, a spectacular advancement 10 the under~tan 100
of the molecular mechanisms that control food intake an~ ~ody .wetght has
been rep011ed, but to date only two Food and Drug ~dllliJ11stratt?lt (FD~)­
approved medications for chronic weight loss an.d mall1tena~ce, stb~tramll~e
and orli8tat (36) are available in the market. Contll1uous global efforts to tre~t
the obesity pandemic have not been very successfu~ .and novel. ~lerapeuttc
aCTents are uroently required. In this respect, traditlOnal medlcme offers
v~rious herbal dietary supplements for reducing body weight that warrant
further consideration in the light of risk-benefit balance sc?recard. .
. Due to the financial and psychosocial stress of bel~g overwe.lght, the
patients often turn to over-the-counter (OTe) propnetary weIght-loss
products containing single or multiple dieta~y supplel~lents .(e.g:, he~'bs,
vitamins, minerals, amino acid'»). The nutraceuttcals mentIOned 111 thIS artt~le
have been clinicaIly evaluated and some have be~n mark~ted ~o~' obestty
control and weight management. From the reported 1I1forma~lOn, It ~s clearly
evident that the hydroxycitric acid has been extensively studied for tts safety
and efficacy.
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